"The Future of Travel": Trip.com Group to Showcase Next-Gen Tech at ITB Berlin 2025

Trip.com Group to launch joint Technology Game Changers: Future Trends in Travel & Tourism report at ITB Berlin Press Conference

02-26

Ericsson announces changes to the Executive Team and to the Market Area structure

Per Narvinger,currently Head of Business Area Cloud Software and Services,is appointed Executive Vice President and new Head of Business Area Networks as of March 15,2025

02-26

ChipMOS REPORTS FOURTH QUARTER AND FULL YEAR 2024 RESULTS

6.3% Increase in Full Year 2024 Revenue Compared to Prior Year 13.0% Full Year 2024 Gross Margin Compared to 16.6% in 2023

02-26

BioCity Announces its selective Endothelin Type-A Receptor Antagonist, SC0062, Met the Primary Endpoint in Diabetic Kidney Disease (DKD) in a Phase 2 trial (2-SUCCEED)

SHANGHAI,Feb. 23,2025-- BioCityBiopharma (BioCity) announced that its selective endothelin receptor type A (ETA) antagonist,SC0062,met the 12-week primary endpoint of a reduction in proteinuria in the

02-26

China committed to acting as an 'enabler'

BEIJING,Feb. 25,2025-- A report from People\'s Daily: Recently,a foreign scholar described China as an "enabler." This term vividly encapsulates China\'s commitment to building a community w

02-26

IIIF150 Unveils Latest Flagship Raptor 5G at MWC2025

BARCELONA,Spain,Feb. 25,2025-- IIIF150,the imaginative ultra-thin rugged phone manufacture,announced their new flagship Raptor 5G which will be showcased in Barcelona,and different tests onsite to cha

02-26

Lessons from Japan's AMR Response for the Global Community

https://iris.who.int/handle/10665/380481 TOKYO,Feb. 25,2025-- World Health Organization (WHO) Regional Office for the Western Pacific (WPRO) has released Japan\'s AMR Response 2013–2025 alongside Tok

02-26

MicuRx Pharmaceutical: Contezolid Global Phase III Clinical Trial Safety and Efficacy Evaluation Endorsed by Data Monitoring Committee, Promising Prospects for Diabetic Foot Infection Treatment

Data Monitoring Committee (DMC) has completed the first safety and efficacy assessment of the global Phase III clinical trial,recommending continued progression as planned

02-26

teamLab Phenomena Abu Dhabi Will Open on 18 April Within Saadiyat Cultural District Abu Dhabi

ABU DHABI,UAE,Feb. 25,2025--teamLab Phenomena Abu Dhabiwill officially open its doors to the public in Saadiyat Cultural District Abu Dhabi on 18 April 2025,announced by the Department of Culture and

02-26

KT&G to Hold 38th Annual General Meeting

- Annual General Meeting on Mar. 26th,agendas include director appointment SEOUL,South Korea,Feb. 25,2025-- KT&G Corporation ("KT&G" or the "Company") (KRX:033780) held a

02-26